Adverum Biotechnologies, Inc. (ADVM) Insider Trading -- Recent Executive & Director Transactions
13 insiders reported 44 Form 4 transactions for Adverum Biotechnologies, Inc. (ADVM) over the past 18 months (most recent 2025-12-10). Recent activity: Rubinstein Linda M (CHIEF FINANCIAL OFFICER) Buy 48,750 shares, Machado Patrick (Director) Sell 8,818 shares, Seyedkazemi Setareh (CHIEF DEVELOPMENT OFFICER) Sell 8,125 shares, Seyedkazemi Setareh (CHIEF DEVELOPMENT OFFICER) Buy 85,000 shares, Seyedkazemi Setareh (CHIEF DEVELOPMENT OFFICER) Sell 88,332 shares. Source: SEC Form 4.
| Date | Insider | Title | Type | Shares | Value |
|---|---|---|---|---|---|
| 2025-12-10 | Rubinstein Linda M | CHIEF FINANCIAL OFFICER | Buy | 48,750 | $204,750 |
| 2025-12-10 | Machado Patrick | Director | Sell | 8,818 | $0 |
| 2025-12-10 | Seyedkazemi Setareh | CHIEF DEVELOPMENT OFFICER | Sell | 8,125 | $0 |
| 2025-12-10 | Seyedkazemi Setareh | CHIEF DEVELOPMENT OFFICER | Buy | 85,000 | $0 |
| 2025-12-10 | Seyedkazemi Setareh | CHIEF DEVELOPMENT OFFICER | Sell | 88,332 | $0 |
| 2025-12-10 | Ozden Rabia Gurses | Chief Medical Officer | Sell | 8,125 | $0 |
| 2025-12-10 | Ozden Rabia Gurses | Chief Medical Officer | Buy | 85,000 | $0 |
| 2025-12-10 | Scopa James Paul | Director | Sell | 10,333 | $0 |
| 2025-12-10 | Soparkar Peter | CHIEF OPERATING OFFICER | Sell | 80,189 | $0 |
| 2025-12-10 | Soparkar Peter | CHIEF OPERATING OFFICER | Sell | 13,125 | $0 |
| 2025-12-10 | Soparkar Peter | CHIEF OPERATING OFFICER | Buy | 150,000 | $0 |
| 2025-12-10 | Soparkar Peter | CHIEF OPERATING OFFICER | Sell | 157,333 | $0 |
| 2025-12-10 | Svoronos Dawn | Director | Sell | 5,000 | $0 |
| 2025-12-10 | Lupher, Jr. Mark L. | Director | Sell | 13,000 | $0 |
| 2025-12-10 | Fischer Laurent | CEO, PRESIDENT AND DIRECTOR | Buy | 150,000 | $630,000 |
| 2025-12-10 | Fischer Laurent | CEO, PRESIDENT AND DIRECTOR | Sell | 351,513 | $0 |
| 2025-12-10 | Fischer Laurent | CEO, PRESIDENT AND DIRECTOR | Sell | 25,000 | $0 |
| 2025-12-10 | Fischer Laurent | CEO, PRESIDENT AND DIRECTOR | Buy | 500,000 | $0 |
| 2025-12-10 | Fischer Laurent | CEO, PRESIDENT AND DIRECTOR | Sell | 522,666 | $0 |
| 2025-12-10 | Seyedkazemi Setareh | CHIEF DEVELOPMENT OFFICER | Sell | 54,874 | $0 |
| 2025-12-10 | Rubinstein Linda M | CHIEF FINANCIAL OFFICER | Sell | 61,150 | $0 |
| 2025-12-10 | Rubinstein Linda M | CHIEF FINANCIAL OFFICER | Sell | 8,125 | $0 |
| 2025-12-10 | Rubinstein Linda M | CHIEF FINANCIAL OFFICER | Buy | 42,000 | $0 |
| 2025-12-10 | Rubinstein Linda M | CHIEF FINANCIAL OFFICER | Sell | 42,000 | $0 |
| 2025-12-10 | Ozden Rabia Gurses | Chief Medical Officer | Sell | 85,000 | $0 |
Source: SEC Form 4 filings · as of 2025-12-10